Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19

被引:9
|
作者
Smit, Wouter L. [1 ,2 ]
van Tol, Sophie [3 ]
van der Wal, Sanne [1 ]
van Vulpen, Femke [1 ]
la Grouw, Shannon [1 ]
van Lelyveld, Lenneke [4 ]
Limonard, Gijs [5 ]
Bossink, Ailko [5 ]
Godeke, Gert-Jan [3 ]
Shrestha, Sandhya [3 ]
Reimerink, Johan [3 ]
Eggink, Dirk [3 ]
Reusken, Chantal [3 ]
Heron, Michiel [1 ]
Thijsen, Steven [1 ]
机构
[1] Diakonessenhuis Utrecht, Dept Med Microbiol & Immunol, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands
[3] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands
[4] Diakonessenhuis Utrecht, Dept Intens Care, Utrecht, Netherlands
[5] Diakonessenhuis Utrecht, Dept Pulm Dis, Utrecht, Netherlands
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
SARS-CoV-2; COVID-19; spike protein; seasonal coronaviruses; immune imprinting; SARS-COV-2;
D O I
10.3389/fimmu.2022.839367
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Defining immune correlates of disease severity is important to better understand the immunopathogenesis in COVID-19. Here we made use of a protein microarray platform to detect IgG- and IgA-reactive antibodies in sera and saliva respectively, and assess cross-reactivity between SARS-CoV-2 and endemic coronaviruses (eCoVs). IgG responses against the full protein of spike, but not the S1 subunit, were significantly higher in convalescent sera of patients with severe disease compared to mild disease and healthy controls. In addition, we detected reactivity of secretory IgA to eCoVs in saliva of patients with severe disease, not present in patients with moderate disease or seropositive healthy controls. These heterologous immune responses are in line with non-protective cross-reactivity, and support a potential role for immune imprinting in the pathogenesis of severe COVID-19.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Homologous or heterologous COVID-19 vaccine schemes: comparison of immune responses and side effects
    Karaali, Ridvan
    Dinc, Harika Oyku Oyku
    Balkan, Ilker Inanc
    Can, Gunay
    Keskin, Elif
    Colak, Hatice
    Dasdemir, Ferhat Osman
    Aydogan, Okan
    Budak, Beyhan
    Kaya, Sibel Yildiz
    Kocazeybek, Bekir
    Saltoglu, Nese
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2023, 107 (02)
  • [32] Immune responses of MIS-C and severe COVID-19 patients
    Bildik, Tugce
    Bartan, Asli Gulce
    Ozsurekci, Yasemin
    Saraydar, Berfu
    Evcili, Irem
    Turay, Nilsu
    Ibibik, Bilgehan
    Bulbul, Artun
    Yildirim, Muzaffer
    Yildirim, Tugce
    Ceylan, Yasemin
    Abras, Irem
    Gursel, Ihsan
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 236 - 236
  • [33] Immunometabolism and potential targets in severe COVID-19 peripheral immune responses
    Wang, Shanshan
    Zeng, Xian
    Wang, Yali
    Chen, Yuzong
    Wang, Chaoxin
    Zhuoma, Dongzhi
    Zhang, Fengying
    Zhao, Yufen
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 16 (06) : 665 - 667
  • [34] High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines
    Joseph, Janet O.
    Ylade, Michelle
    Daag, Jedas Veronica
    Aogo, Rosemary
    Crisostomo, Maria Vinna
    Mpingabo, Patrick
    Premkumar, Lakshmanane
    Deen, Jacqueline
    Katzelnick, Leah C.
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [35] First antibody against COVID-19 spike protein enters phase I
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (07) : 435 - 435
  • [36] First antibody against COVID-19 spike protein enters phase I
    Asher Mullard
    Nature Reviews Drug Discovery, 2020, 19 (7) : 435 - 435
  • [37] Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19
    Martin-Vicente, Maria
    Berenguer, Juan
    Jose Munoz-Gomez, Maria
    Diez, Cristina
    Mican, Rafael
    Jesus Perez-Elias, Maria
    Jesus Garcia-Fraile, Lucio
    Peraire, Joaquin
    Suarez-Garcia, Ines
    Angeles Jimenez-Sousa, Maria
    Fernandez-Rodriguez, Amanda
    Vazquez, Monica
    Ryan, Pablo
    Gonzalez-Garcia, Juan
    Jarrin, Inmaculada
    Mas, Vicente
    Martinez, Isidoro
    Resino, Salvador
    JOURNAL OF INFECTION, 2022, 84 (03) : 444 - 448
  • [38] Durability of immune responses to mRNA booster vaccination against COVID-19
    Arunachalam, Prabhu S.
    Lai, Lilin
    Samaha, Hady
    Feng, Yupeng
    Hu, Mengyun
    Hui, Harold Sai-yin
    Wali, Bushra
    Ellis, Madison
    Davis-Gardner, Meredith E.
    Huerta, Christopher
    Bechnak, Kareem
    Bechnak, Sarah
    Lee, Matthew
    Litvack, Matthew B.
    Losada, Cecilia
    Grifoni, Alba
    Sette, Alessandro
    Zarnitsyna, Veronika I.
    Rouphael, Nadine
    Suthar, Mehul S.
    Pulendran, Bali
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (10):
  • [39] The serological diversity of serum IgG/IgA/IgM against SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan
    Kaneko, Yudai
    Sugiyama, Akira
    Tanaka, Toshiya
    Fukui, Kazushige
    Taguchi, Akashi
    Nakayama, Aya
    Koga, Kazumasa
    Kishi, Yoshiro
    Daming, Wang
    Qian, Chungen
    Xia, Fuzhen
    He, Fan
    Zheng, Liang
    Yu, Yi
    Wada, Youichiro
    Wada, Yoshiaki
    Kodama, Tatsuhiko
    Kawamura, Takeshi
    HEALTH SCIENCE REPORTS, 2022, 5 (03)
  • [40] Analysis of IgG Antibodies against SARS-CoV-2 and Seasonal Coronaviruses in Vaccinated Adults against COVID-19, 2021
    Recalde-Reyes, Delia Piedad
    Rodriguez-Salazar, Carlos Andres
    INFECTIO, 2024, 28 (03) : 145 - 151